Author:
Dai Yanmei,Zeng Xu,Zhao Sheng,Hu Hongbo,Li Jinping,Liang Zong-Hui,Jia Fucang,Jiang Huijie
Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
2. Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. In: Mechanisms and therapy of liver cancer. Amsterdam: Elsevier; 2021. p. 1–61.
3. Lee Y, Wang JJ, Luu M, Noureddin M, Nissen NN, Patel TC, et al. Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States. Hepatology. 2021;74:2622–32. https://doi.org/10.1002/hep.32007.
4. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264-1273.e1.
5. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127:S87–96.